CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...